Skip to main content
NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.52%AUDCHF+0.43%GBPTRY+0.41%NZDCHF+0.41%USDCAD-0.39%EURCAD-0.34%CADJPY+0.34%GBPHKD+0.32%GBPUSD+0.30%GBPMXN-0.28%AUDSGD+0.28%USDTRY+0.28%EURCHF+0.27%NZDSGD+0.25%CHFJPY-0.25%GBPJPY+0.24%NZDUSD+0.23%AUDUSD+0.22%EURGBP-0.22%USDCHF+0.21%USDNOK-0.21%NZDCAD-0.20%GBPSGD+0.19%NZDMXN+0.18%USDZAR-0.18%AUDJPY+0.17%AUDCAD-0.17%EURSGD+0.16%USDILS+0.16%NZDJPY+0.16%NOKJPY+0.16%CHFSGD+0.15%USDPLN-0.15%USDSEK-0.15%EURAUD-0.14%CHFNOK-0.12%AUDDKK+0.12%EURNZD-0.12%SGDJPY-0.11%EURNOK-0.11%PLNJPY+0.10%EURHKD+0.10%USDDKK-0.10%GBPAUD+0.09%EURZAR-0.08%GBPCAD-0.08%EURCNH+0.07%GBPNZD+0.07%USDTHB+0.07%EURUSD+0.06%USDSGD+0.06%CHFSEK-0.06%GBPZAR-0.06%EURPLN-0.05%EURSEK-0.05%USDJPY-0.05%USDCOP-0.04%EURJPY+0.02%AUDNZD+0.02%USDCNH-0.02%USDMXN-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK+0.01%EURDKK0.00%COTTON+0.90%HG1+0.74%S1+0.42%XNGUSD+0.41%UKOIL-0.27%USOIL-0.26%W1-0.25%XAGUSD+0.09%GAGUSD+0.09%C1-0.05%GAUUSD+0.04%XAUUSD+0.04%BTCUSD+2.52%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.78%DOGEUSD+14.12%XMRUSDT+5.57%LINKUSD+13.42%XLMUSD+0.29%BCHUSDT+5.71%UNIUSD+7.23%LTCUSD+9.66%SUIUSD+3.56%HBARUSDT+0.50%TONUSD+26.15%TAOUSDT+3.92%AAVEUSD+3.69%DOTUSDT+0.06%ICPUSDT+0.56%ONDOUSDT+0.47%WLDUSDT+0.17%ARBUSDT+7.07%JUPUSDT+0.62%ATOMUSDT+1.62%INJUSDT+14.60%STXUSDT+5.78%FETUSDT+3.07%TIAUSDT+9.38%PYTHUSDT-0.53%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+21.23%GRTUSDT+3.94%IOTAUSDT+0.81%WIFUSDT+2.70%AXSUSDT-1.66%POLUSDT+2.83%FARTCOINUSDT+1.01%EOSUSDT+2.16%DYDXUSDT+3.68%GALAUSDT-1.87%ORDIUSDT+0.11%RONINUSDT-3.42%NOTUSDT+1.21%NVDA+0.21%AAPL-0.23%GOOGL+0.30%MSFT-0.42%AMZN-0.29%TSM+0.17%SPCX-4.21%META+0.03%AVGO+0.73%TSLA-0.15%BRK-B+0.61%SKHY-3.19%LLY-1.36%MU+0.27%AMD+1.90%WMT-0.71%JPM-0.86%V+1.74%XOM+1.12%ASMLa-4.20%JNJ-5.73%MA+1.63%INTC+1.44%0700.HK-0.03%ABBV-2.40%1398.HK-1.41%CSCO-0.23%CVX+1.27%COST-0.50%ORCL+4.23%KO+0.36%BAC-1.14%DELL-0.72%LRCX-2.73%AMAT-6.69%PG-0.10%AP2d-8.45%CAT-3.33%UNH-0.20%3988.HK-1.16%1816.HK-25.11%0005.HK-1.09%HSBA.L+0.17%0857.HK+0.29%GE-0.33%PM-1.34%0939.HK-1.63%1288.HK-2.19%MS-1.78%NFLX-0.21%CADCHF+0.61%GBPCHF+0.52%AUDCHF+0.43%GBPTRY+0.41%NZDCHF+0.41%USDCAD-0.39%EURCAD-0.34%CADJPY+0.34%GBPHKD+0.32%GBPUSD+0.30%GBPMXN-0.28%AUDSGD+0.28%USDTRY+0.28%EURCHF+0.27%NZDSGD+0.25%CHFJPY-0.25%GBPJPY+0.24%NZDUSD+0.23%AUDUSD+0.22%EURGBP-0.22%USDCHF+0.21%USDNOK-0.21%NZDCAD-0.20%GBPSGD+0.19%NZDMXN+0.18%USDZAR-0.18%AUDJPY+0.17%AUDCAD-0.17%EURSGD+0.16%USDILS+0.16%NZDJPY+0.16%NOKJPY+0.16%CHFSGD+0.15%USDPLN-0.15%USDSEK-0.15%EURAUD-0.14%CHFNOK-0.12%AUDDKK+0.12%EURNZD-0.12%SGDJPY-0.11%EURNOK-0.11%PLNJPY+0.10%EURHKD+0.10%USDDKK-0.10%GBPAUD+0.09%EURZAR-0.08%GBPCAD-0.08%EURCNH+0.07%GBPNZD+0.07%USDTHB+0.07%EURUSD+0.06%USDSGD+0.06%CHFSEK-0.06%GBPZAR-0.06%EURPLN-0.05%EURSEK-0.05%USDJPY-0.05%USDCOP-0.04%EURJPY+0.02%AUDNZD+0.02%USDCNH-0.02%USDMXN-0.01%EURCZK+0.01%USDHKD+0.01%AUDNOK+0.01%EURDKK0.00%COTTON+0.90%HG1+0.74%S1+0.42%XNGUSD+0.41%UKOIL-0.27%USOIL-0.26%W1-0.25%XAGUSD+0.09%GAGUSD+0.09%C1-0.05%GAUUSD+0.04%XAUUSD+0.04%BTCUSD+2.52%ETHUSD+17.67%USDTUSD+0.02%XRPUSD+11.86%SOLUSD+12.05%TRXUSDT+0.77%ZECUSDT+8.78%DOGEUSD+14.12%XMRUSDT+5.57%LINKUSD+13.42%XLMUSD+0.29%BCHUSDT+5.71%UNIUSD+7.23%LTCUSD+9.66%SUIUSD+3.56%HBARUSDT+0.50%TONUSD+26.15%TAOUSDT+3.92%AAVEUSD+3.69%DOTUSDT+0.06%ICPUSDT+0.56%ONDOUSDT+0.47%WLDUSDT+0.17%ARBUSDT+7.07%JUPUSDT+0.62%ATOMUSDT+1.62%INJUSDT+14.60%STXUSDT+5.78%FETUSDT+3.07%TIAUSDT+9.38%PYTHUSDT-0.53%SEIUSDT+4.57%IMXUSDT+0.63%OPUSDT+21.23%GRTUSDT+3.94%IOTAUSDT+0.81%WIFUSDT+2.70%AXSUSDT-1.66%POLUSDT+2.83%FARTCOINUSDT+1.01%EOSUSDT+2.16%DYDXUSDT+3.68%GALAUSDT-1.87%ORDIUSDT+0.11%RONINUSDT-3.42%NOTUSDT+1.21%
LT

Larimar Therapeutics, Inc. (LRMR)

NASDAQ • Healthcare

$2.16
-$0.36 (-14.6%)
Market closed

Last close at October 13, 2026 at 20:00 UTC

Open$2.53
Day Range$2.13 - $2.53
Avg. Volume (3M)1.4M
Market Cap$224.3M
52 Week Range
$2.13$6.42
Next EarningsIn 22 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$172.6M
EPS (TTM)
-$1.99
ROA (TTM)
-104.42%
Current Ratio
4.7

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-65.9%Q1 2026-$0.73
+41.5%Q2 2026-$0.31
+21.4%Q3 2026-$0.3
Next

Nov 5

in 22 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Next report — what to expect

Larimar Therapeutics, Inc. (LRMR) is set to report earnings on November 5, 2026. Consensus calls for EPS of -$0.37. The company has beaten EPS in 4 of 8 most recent quarters, so attention will be on whether results and commentary align with that cadence around the release.

View full earnings history

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc. is a NASDAQ-listed healthcare company in biotechnology that operates as a clinical-stage drug developer focused on rare diseases. The company centers its work on CTI-1601, a therapy candidate for Friedreich's ataxia, and its current profile is that of an early-stage biotech rather than a commercial medicine business.

Name
Larimar Therapeutics, Inc.
CEO
Carole S. Ben-Maimon
Website
www.larimartx.com
Industry
Healthcare
Employees
71

Today's Snapshot

AI-generated

LRMR closed 14.6% lower at 2.16, in line with a weaker sector. Trading was busier than usual, with volume roughly twice its usual level.

Trading Volume

Above 10d avg 1.1M

2.5M

vs S&P 500 Today

Strong Underperformance

-14.60%

Updated: October 13, 2026 at 20:10 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
LRMR shows characteristics of a strong downtrend even as short-term oscillators read deeply oversold: RSI, Stochastic and Williams %R signal buy/oversold levels, but MACD and momentum remain negative and price sits well below short-, medium- and long-term moving averages. ADX is elevated, indicating a strong directional move, and ATR is high which signals outsized volatility; on-balance volume also points to selling pressure and the pivot lies above the market. Technical takeaway: Strong Sell — oversold indicators contrast with dominant trend, volatility and volume favor further downside.
All signals
  • EMA (5 indicators)$2.74 - $3.80
    Sell
  • RSI (14)16.47
    Buy
  • Stochastic %K (14, 3, 3)2.05
    Buy
  • MACD Level (12, 26)-0.37
    Sell

Peers & Related Assets

ANNXAnnexon, Inc.
$3.83-3.3%
ALTAltimmune, Inc.
$2.43-5.1%
LXEOLexeo Therapeutics, Inc. Common Stock
$2.74-9.9%
KRROKorro Bio, Inc.
$8.81-6.0%
ANROAlto Neuroscience, Inc.
KYTXKyverna Therapeutics, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.